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The Journal of Immunology
Cytokine BAFF Released by Helicobacter pylori–Infected
Macrophages Triggers the Th17 Response in Human
Chronic Gastritis
Fabio Munari,* Matteo Fassan,† Nagaja Capitani,‡,x Gaia Codolo,* Marian Vila-Caballer,*
Marco Pizzi,{ Massimo Rugge,{ Chiara Della Bella,‡ Arianna Troilo,‡ Sofia D’Elios,‡
Cosima T. Baldari,x Mario M. D’Elios,‡ and Marina de Bernard*
BAFF is a crucial cytokine that affects the activity of both innate and adaptive immune cells. It promotes the expansion of Th17
cells in autoimmune disorders. With this study, we investigated the BAFF/Th17 responses in Helicobacter pylori–induced
gastritis in humans. Our results show that the mucosa from Helicobacter+ patients with chronic gastritis is enriched in IL-
17 and BAFF, whereas the two cytokines are weakly expressed in Helicobacter2 patients with chronic gastritis; moreover, the
expression of both BAFF and IL-17 decreases after bacteria eradication. We demonstrate that BAFF accumulates in macro-
phages in vivo and that it is produced by monocyte-derived macrophages in vitro, after Helicobacter stimulation. Application of
BAFF on monocytes triggers the accumulation of reactive oxygen species that are crucial for the release of pro-Th17 cytokines,
such as IL-23, IL-1b, and TGF-b. Moreover, BAFF directly promotes the differentiation of Th17 cells. In conclusion, our
results support the notion that an axis BAFF/Th17 exists in chronic gastritis of Helicobacter+ patients and that its presence
strictly depends on the bacterium. Moreover, we demonstrated that BAFF is able to drive Th17 responses both indirectly, by
creating a pro-Th17 cytokine milieu through the involvement of innate immune cells, and directly, via the differentiation of
T cells toward the specific profile. The results obtained in this study are of great interest for Helicobacter-related diseases and
the development of novel therapeutic strategies based on the inhibition of the BAFF/IL-17 response. The Journal of Immu-
nology, 2014, 193: 5584–5594.
H
elicobacter pylori is a Gram-negative bacterium that
establishes chronic infection in the stomach. Coloniza-
tion often remains asymptomatic but, in some cases, it
can progress into gastritis, gastric ulcer, and gastric malignancies.
It is known that the infection by the bacterium is accompanied by
a Th1 immune response that, instead of being useful for clearing
the bacterium, is probably responsible for the mucosa damage (1).
The paradigm that the Th1 profile is the only one that sustains
H. pylori–associated diseases has been recently revised, because it
has been demonstrated that other proinflammatory cytokines, be-
sides IFN-g, such as IL-17 and TNF-a, are also involved (2).
It has been proposed that Th17 cells precede and may regulate
the Th1 response and contribute to the pathology in mice (3), but
the real contribution of the IL-17 activity in H. pylori–induced
diseases remains a controversial issue. Many data support the idea
that the Th17 response favors the bacterial growth in mice and
contributes to the inflammation both in mice and in humans (3–5),
although its role is probably not essential because IFN-g has the
largest effect (2). Along with this evidence, other data suggest that
this response may exert a regulatory effect rather than a proin-
flammatory one (6). Moreover, conflicting data are also available
on the role of Th17 cells in tumors: some findings support a
promoting activity, whereas others suggest an inhibitory action.
However, these conflicts are more apparent than real, because the
biological impact of Th17 cells depends critically on the type of
cancer (7). In the case of gastric cancer, a recent study demon-
strated that Th17 cells infiltrate the tumor and that the secreted
IL-17 leads to tumor progression (8).
Macrophages have been suggested to play a central role in
driving the differentiation of Th17 cells inH. pylori–infected mice;
indeed, upon the application of the bacterium or of its virulence
factor urease, macrophages release pro-Th17 cytokines (9, 10).
Moreover, two recent studies conducted on two different mouse
models of autoimmune disorders identified in the BAFF (also
named BLyS) of the TNF-a family a promoting factor for the
Th17 response (11, 12). One study suggests a direct role of the cy-
tokine in the generation of this immune profile, whereas the
other one leans toward an indirect role for BAFF as modulator
for the cytokine milieu, which, in turn, would affect the gen-
eration and function of Th17 cells.
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Despite this growing amount of knowledge in mice, little is
known about the mechanism of CD4+ T cell differentiation into
Th17 cells in H. pylori–infected humans, both in terms of cells
involved and in terms of the contribution of both bacterial and host
factors.
In this study, we demonstrate that the mucosa of H. pylori–
infected subjects, affected by chronic gastritis, is enriched in IL-17
and BAFF, and that the accumulation of the two cytokines is strictly
dependent on the presence of the bacterium. We found that BAFF is
mainly secreted by macrophages, which are abundant in the gastric
mucosa of patients, and by acting on monocytes, it triggers the
release of pro-Th17 cytokines in a reactive oxygen species (ROS)–
dependent manner. Interestingly, BAFF is capable of promoting the
differentiation of Th17 cells also by acting directly on proliferating
human CD4+ T cells.
Collectively, our results suggest that BAFF, which accumulates
in the mucosa of H. pylori–infected patients with chronic gastritis,
might be one of the host factors that participate in generating Th17
cells.
Materials and Methods
Reagents
PBS, RPMI 1640, and FBS were from Euroclone (Siziano, Italy). Genta-
micin, HEPES, HBSS, TRIzol solution, Hoechst stain, SuperScript II, anti-
rat Alexa 488, anti-mouse Alexa 488, and anti-mouse Alexa 594 secondary
Abs were from Life Technologies (Glasgow, U.K.); diphenyleneiodonium
(DPI) chloride, Triton X-100, Tween 20, sodium citrate, BSA, forskolin, the
Jak inhibitor AG490, and the protein kinase A (PKA) inhibitor H89 were
from Sigma-Aldrich (St. Louis, MO); 29,79-dichlorofluorescein diacetate
(H2DCF-DA) was from Cayman Chemical (Ann Harbor, MI). Recombi-
nant human BAFF (rBAFF) and M-CSF were from Immunological Science
(Rome, Italy). Rat anti-human BAFF blocking Ab was from R&D Systems
(Minneapolis, MN). Rat anti-human BAFF polyclonal Ab was from Alexis
Biochemicals (San Diego, CA); rabbit anti-human IL-17 and mouse anti-
human CD68 Abs were from Santa Cruz Biotechnology (Santa Cruz, CA).
mAbs anti-human CD3 and anti-human CD28 were from BD Biosciences
(Saint Jose, CA). mAb anti-human CD4 was from Abcam (Cambridge,
U.K.). Monoclonal blocking Ab anti-human TLR2 (clone TL2.1) was from
eBioscience (High Wycombe, U.K.); monoclonal blocking Ab anti-human
TLR4 (W7C11) was from Invivogen (Toulouse, France). mAb anti-human
phospho-CREB (Ser133) and rabbit polyclonal Ab against the phosphory-
lated PKA consensus phosphorylation site, R-X-X-pT-X-X/R-R-X-pS-X-X,
were from Cell Signaling Technology (Danvers, MA). Monoclonal anti-
actin Ab was from Merck-Millipore (Darmstadt, Germany). Ficoll-
Paque solution and Percoll were from GE Healthcare Life Science
(Buckinghamshire, U.K.). Human IL-23, IL-1b, and IL-6 were from eBio-
science (San Diego, CA). Neutralizing anti–IL-4 Ab was from Biolegend
(San Diego, CA), and neutralizing anti–IL-12 Ab was from Serotec (Oxford,
U.K.). StemSep Human T-cell enrichment kit was from Voden Medical
Instruments (Milan, Italy).
Patients
The cases considered in this study were retrospectively collected from the
files of the Surgical Pathology and Cytopathology Unit at the University of
Padua (January 2003 to December 2011). All patients were white and native
of the Veneto region, and they underwent endoscopy at Padua University
Hospital. The institute’s ethical regulations on research conducted on
human tissues were followed.
The study was conducted on a total of 40 endoscopic biopsy samples
obtained from different biopsy sets and all collected from oxyntic proximal
mucosa (i.e., gastric corpus). The series included: 1) normal gastric oxyntic
mucosa obtained from dyspeptic patients, as control (n = 10); 2) mucosa
from H. pylori2 nonatrophic chronic gastritis (n = 10); 3) mucosa from
H. pylori+ nonatrophic chronic gastritis, before H. pylori eradication therapy
(ET; n = 10); and 4) mucosa from the same patients as in 3), who un-
derwent clinical and histological remission, after H. pylori ET. H. pylori
was assessed by histology (modified Giemsa staining) and confirmed by
clinical history, rapid urease testing, and/or ELISA (H. pylori–specific IgG
Abs; GastroPanel, Biohit HealthCare, Milan, Italy) (13). Two trained
gastrointestinal pathologists, blinded to any of the patients’ endoscopic or
clinical information, jointly assessed the original slides (H&E, Alcian
blue–periodic acid schiff, and Giemsa for H. pylori). The semiquantitative
assessment of the severity of mononuclear inflammation was graded in
a three-tier scale (Supplemental Table I): grading is defined as the measure
of the severity of the mononuclear inflammatory lesions and was evaluated
according to Dixon and colleagues (14).
Immunofluorescence on tissue slices
Tissues were obtained from the archive of the Surgical Pathology
and Cytopathology Unit at the University of Padua. Four-micrometer,
formalin-fixed, paraffin-embedded tissue sections were deparaffinized
with xylene washes and rehydrated with decreasing ethanol concen-
tration. Heat-mediated Ag retrieval was obtained with repeated heat
cycles in microwave for 10 min in retrieval buffer (10 mM sodium citrate,
pH 6, 0.05% Tween 20). After permeabilization (45 min in 0.2% Triton
X-100 in PBS), sections were blocked in 10% goat serum, 1% BSA in
PBS for 1 h.
Abs specific for BAFF, IL-17, CD4, and CD68 were added to sections
and revealed with Alexa-labeled secondary Abs. Nuclei were detected by
the Hoechst stain. Slices were visualized with an oil immersion objective on
a laser-scanning confocal microscope, and images were acquired using the
LAS-AF software (Leica TCS-SP5; Leica Microsystems, Wetzlar, Ger-
many). Quantification of the expression level of IL-17 and BAFF was
performed using ImageJ software.
Bacterial strain and growth conditions
CagA+/VacA+ H. pylori strain 342, CagA+/VacA+ H. pylori strain G27, and
their isogenic mutants Dhp-nap (15, 16) and DcagPAI (17) were provided
by A. Covacci, Novartis Vaccines, Siena, Italy; Cag+/VacA+ H. pylori
strain SPM326 and its isogenic mutant DvacA (15, 18) were provided by
J.L. Telford, Novartis Vaccines. H. pylori strains were maintained in 5%
CO2 at 37˚C on Columbia agar plates supplemented with 5% horse blood.
Colonies were inoculated into brain heart infusion broth containing 5%
FBS and were cultured for 2 d in rotary shaking at 180 rpm at 37˚C under
microaerophilic conditions.
Monocyte isolation, macrophage differentiation, and cell
treatment
Monocytes from healthy donors were prepared as described previously (19).
For macrophage differentiation, 5 3 105 monocytes, seeded in 24-well
plates, were cultured in RPMI 20% FBS in the presence of 100 ng/ml
M-CSF for a 6-d differentiation. Monocyte-derived macrophages (MDMs)
were cultured for 1 d in culture medium without M-CSF, before stimuli
application. Cells were cultured in RPMI 1640 containing 10% FCS in the
presence of BAFF (50 ng/ml), bacteria (multiplicity of infection [MOI] =
0.5), or PBS (control). When required, cells were preincubated for 1 h with
20 mM DPI, 10 mM H89, 25 mM AG490, 20 mg/ml anti-TLR2 Ab, or 10
mg/ml anti-TLR4 Ab.
For the experiments aimed to address the signaling pathway triggered
by H. pylori, macrophages were incubated or not with bacteria (strain
SPM326 wild type [wt], MOI = 0.5) for 2 h at 37˚C. When required, cells
were preincubated 1 h with 10 mM H89. Cells were recovered by centri-
fugation, washed twice in PBS, and lysed in 1% Triton X-100 in 20 mM
Tris-HCl (pH 8.0), 150 mM NaCl in the presence of protease inhibitors.
Samples were centrifuged at 16,000 3 g for 20 min at 4˚C, and the
postnuclear supernatants were collected and processed for immunoblot
analysis.
For the experiment with BAFF blocking Ab, the latter, used at the final
concentration of 1 mg/ml, was preincubated for 1 h with BAFF in culture
medium, before adding to the cells. For the experiment with the H. pylori–
conditioned medium of MDMs, the latter were infected with bacteria
(MOI = 0.5) for 72 h. The medium was collected, clarified by centrifu-
gation, and applied on freshly isolated monocytes in presence or absence
of anti-BAFF blocking Ab. After 96 h, supernatants were collected and
the amount of extracellular cytokines was determined by ELISA.
Real-time PCR analysis
Total mRNA was isolated from paraffin-embedded biopsies using the
RecoverAll Total Nucleic Acid Isolation Kit (Life Technologies). mRNA
extraction frommonocytes was performed using TRIzol Reagent, according
to the manufacturer’s specifications. mRNA was reverse-transcribed using
SuperScript II, and cDNA was amplified with the following primers:
GAPDH, 59-AGCAACAGGGTGGTGGAC-39 and 59-GTGTGGTGGGG-
GACTGAG-39; IL-23p19, 59-TCCACCAGGGTCTGATTTTT-39 and 59-
TTGAAGCGGAGAAGGAGACG-39; IL-12p40, 59-ACAAAGGAGGC-
GAGGTTCTAA-39 and 59-CCCTTGGGGGTCAGAAGAG-39; IL-6, 59-
AACCTGAACCTTCCAAAGATGG-39 and 59-TCTGGCTTGTTCCTC-
ACTACT-39; TGF-b, 59-AGTGGTTGAGCCGTGGAG-39 and 59-CCAT-
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GAGAAGCAGGAAAGG-39; IL-1b, 59-CTGTCCTGCGTGTTGAAAG-
A-39 and 59-TTGGGTAATTTTTGGGATCTACA-39; IL-17, 59-TGGG-
AAGACCTCATTGGTGT-39 and 59-TGGGAAGACCTCATTGGTGT-39;
BAFF, 59-CGGGACTGAAAATCTTTGAACC-39 and 59-TGAGTGAC-
TGTTTCTTCTGGAC-39.
After amplification, data analysis was performed using the second
derivative method algorithm. For each sample, data were normalized to
the endogenous reference gene GAPDH and expressed as arbitrary
units.
cAMP assay
Intracellular cAMP was quantified using an enzyme-linked immunoassay
kit (GE Healthcare, Life Sciences) according to the manufacturer’s
instructions. Cells (1 3 106, plated in 96-well plates in RMPI 1640 sup-
plemented with 20% FCS) were treated with H. pylori strain SPM326 wt
as described earlier. Alternatively, cells were incubated with 25 mM for-
skolin for 30 min in the same conditions. At the end of the treatment, cells
were washed twice in PBS and lysed in the lysis reagent included in the kit.
FIGURE 1. IL-17 expression in dys-
peptic patients with normal mucosa (nor-
mal), H. pylori+ patients (Hp+) with
chronic gastritis pre-ET and post-ET, and
H. pylori2 patients (Hp2) with chronic
gastritis. (A) mRNA was extracted from
gastric biopsies and retro-transcribed.
Expression of IL-17 gene was quantified
as detailed in Materials and Methods.
n = 10 for each group of patients. (B) A
double-immunofluorescence staining was
performed on paraffin-embedded sections
of gastric mucosa using anti-CD4 (green)
and anti–IL-17 (red) Abs followed by
fluorophore-conjugated secondary Abs;
fluorescence intensity associated to IL-17
expression was quantified using ImageJ
software and expressed as mean fluores-
cence intensity (n = 10 for each group of
patients). (C) Representative immunoflu-
orescence staining of a single patient per
group. Nuclei were revealed with Hoechst
33342 stain (blue). Scale bars, 25 mm.
Error bars represent SD. *p , 0.05,
**p , 0.01. AU, arbitrary units; MFI,
mean fluorescence intensity.
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ROS detection
Monocytes (2 3 106 cells/well in a 24-well plate) or MDMs (106 cells/well
in a 24-well plate) were exposed to bacteria (MOI = 0.5), to 50 ng/ml rBAFF,
or to PBS; when required, the cytokine was preincubated with anti-BAFF
blocking Ab or the cells were preincubated with DPI. Cells exposed to PBS
were referred to as control. Cells were incubated with the oxidant-sensitive
probe (H2DCF-DA, 10 mM) in HBSS, glucose 10 mM, for 45 min. After
three washes with HBSS, glucose 10 mM, fluorescence was measured with
a microplate fluorometer with excitation at 485 nm and emission at 530 nm.
Detection of cytokines in culture supernatants
The amount of extracellular cytokines was determined using commercial
ELISA kits, following the manufacturers’ instructions. IL-23 heterodimer,
TGF-b, and IL-6 ELISA kits were purchased from eBioscience (San
Diego, CA); IL-1b ELISA kit was purchased from Biolegend, and BAFF
ELISA kit was purchased from R&D Systems.
ELISPOT assay
Enriched T cells purified from buffy coat from healthy donors by density
gradient centrifugation on Ficoll-Paque, and by using the StemSep Human
T-cell enrichment kit, were activated by anti-CD3 and anti-CD28 mAbs
(10 mg/ml) in the presence or absence of BAFF (100 ng/ml), or anti-BAFF
blocking Ab (10 mg/ml), or human IL-23, IL-1b, IL-6 (10 ng/ml), neu-
tralizing anti–IL-4 (10 mg/ml), and anti–IL-12 (10 mg/ml) Abs. After 10 d,
cells (5 3 105) were washed, stimulated for 48 h using anti-CD3 mAb in
ELISPOT microplates coated with anti–IL-17 Ab (eBioscience, San Diego,
FIGURE 2. BAFF expression in dys-
peptic patients with normal mucosa (nor-
mal), H. pylori+ patients with chronic
gastritis pre- and post-ET, and H. pylori2
patients with chronic gastritis. (A) mRNA
was extracted from gastric biopsies and
retro-transcribed. Expression of BAFF
gene was evaluated. n = 10 for each group
of patients. (B) A double-immunofluores-
cence staining was performed on paraf-
fin-embedded sections of gastric mucosa
using anti-CD68 (green) and anti-BAFF
(red) Abs followed by fluorophore-conju-
gated secondary Abs; fluorescence inten-
sity associated to BAFF expression was
quantified by using ImageJ software and
expressed as mean fluorescence intensity
(n = 10 for each group of patients). (C)
The representative immunofluorescence
staining reveals a clear-cut colocalization
between CD68+ cells and BAFF. Nuclei
were revealed with Hoechst 33342 stain
(blue). Scale bars, 25 mm. Error bars
represent SD. *p , 0.05, **p , 0.01,
***p , 0.001.
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CA), and the number of IL-17–forming cells was measured by an auto-
mated ELISPOT reader as described previously (20).
Statistical analysis
All statistical analyses were performed using Student t test or ANOVA
when applied to patients’ data; data, reported as the mean 6 SD, were
considered significant if p values # 0.05.
Results
IL-17 and BAFF are increased in H. pylori–induced chronic
gastritis and their accumulation correlates with bacterial
infection
The infiltration of Th17 cells in the gastric mucosa of H. pylori–
infected patients is well established (3, 21). To confirm this evi-
dence, we evaluated the expression of IL-17, in terms of both
mRNA and protein, in the mucosa of H. pylori–infected patients
with nonatrophic chronic gastritis, a condition that represents
a risk for the development of more severe gastric diseases (22).
Specimens isolated from the patients were used for extracting total
RNA or processed for immunofluorescence analysis. The latter
was carried out by double staining for CD4 and IL-17. The same
approach was adopted for samples isolated from the same subjects
after bacteria ET and from H. pylori2 patients with chronic gas-
tritis. Normal gastric oxyntic mucosa obtained from dyspeptic
patients was considered as negative control. Fig. 1A reveals a ro-
bust IL-17 mRNA expression in patients infected by H. pylori,
and notably, it dropped after bacteria ET. This observation,
which suggested a correlation between the infection and the
cytokine expression, was further corroborated by the finding that in
H. pylori2 patients, the IL-17 mRNA level remained low. In accor-
dance with these data, IL-17 staining performed on the sections of
different origin revealed an abundant accumulation of the cytokine in
CD4+ cells only in H. pylori patients, whereas the signal was
scanty and more similar to that of normal mucosa, both in post-ET
patients and in H. pylori2 patients; as expected, in the latter two
groups, the infiltration of lymphocytes was practically absent
(Fig. 1B, 1C).
Finally, in accordance with the fact that the Th17 profile is well
represented in H. pylori patients, the same mucosa specimens
enriched in IL-17 showed also an increased expression of IL-6, IL-
1b, IL-23, and TGF-b, the cytokines that play a central role in the
generation of Th17 cells (23). No significant expression of pro-Th17
cytokines was found in the other groups of subjects (Supplemental
Fig. 1). Therefore, the Th17 profile does not accompany indis-
criminately any chronic gastric inflammation; on the contrary, it
appears to be strictly dependent on the presence of H. pylori.
Based on the knowledge that the expansion of Th17 cells
requires BAFF, a trophic factor for B cells, released by various cell
types (11, 12), we next evaluated the expression of BAFF in the
same specimens analyzed for IL-17. We found that the expression
pattern of BAFF was superimposable to that of IL-17, in terms
of both mRNA and protein, being highly represented only in
H. pylori+ patients (Fig. 2A, 2B).
BAFF is expressed by monocytes/macrophages in gastric
mucosa
H. pylori–associated chronic gastritis is characterized by infiltra-
tion of the mucosa by chronic inflammatory cells (monocytes/
macrophages, lymphocytes, plasma cells, and occasional eosino-
phils) and a variable presence of neutrophils (24). Because BAFF
is expressed by a wide variety of cell types, including monocytes,
macrophages, and neutrophils (25, 26), we sought to define the
source of BAFF among the mucosa-infiltrating cells in H. pylori
patients. An immunofluorescence double staining was performed
using Abs specific for either monocytes/macrophages or neu-
trophils together with a mAb anti-BAFF. Neutrophils that were
identified because of their abundant expression of myeloperox-
idase were negative in terms of expression of BAFF (data not
shown). On the contrary, we found an undeniable localization of
the cytokine in monocytes/macrophages, identified as CD68+ cells
(Fig. 2C).
In accordance with the previous data, we found that the exposure
of MDMs to H. pylori induced a time-dependent extracellular
accumulation of BAFF. Notably, monocytes, which also express
CD68, release significantly less BAFF than MDMs upon H. pylori
stimulation (Fig. 3A). Because LPS is capable of inducing BAFF
expression in APCs (26), we addressed the role of the endotoxin in
the induction of BAFF by H. pylori. The receptor involved in the
detection of H. pylori LPS remains a matter of debate: indeed,
although several studies have implicated the classical LPS sensor
TLR4, others support the idea that TLR2 is the main receptor of
FIGURE 3. BAFF production by monocytes and MDMs exposed to
H. pylori. (A) Cells were infected with H. pylori, 106 CFU/ml (MOI = 0.5),
and at the indicated time points culture supernatants were collected for
BAFF content determination. *p , 0.05, ***p , 0.001 versus time 0. (B)
MDMs were preincubated with the indicated Abs before the exposure to
H. pylori; after 72 h, supernatants were collected for BAFF content de-
termination. **p , 0.01. (C) MDMs were infected with wt or mutant
strains of H. pylori; after 72 h, supernatants were collected for BAFF
content determination. Values are expressed as means 6 SD of duplicate
determinations of four separate experiments.
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H. pylori LPS (27). Therefore, we evaluated the release of BAFF
by macrophages exposed to H. pylori in the presence of either
a TLR2 or a TLR4 blocking Ab. Results shown in Fig. 3B imply
an almost exclusive contribution by a ligand of TLR4; however,
because TLR4 (as well as TLR2) participate in the detection of
other non–LPS-related PAMPs of H. pylori (28), we cannot
exclude that ligands other than LPS can be involved. Seeking for
other virulence factor(s) responsible for BAFF secretion, we
finally compared the prosecretory activity of wt bacteria with
that of isogenic strains deficient for the toxin VacA, for the
immune modulant Ag HP-NAP (29), or lacking the entire Cag
pathogenicity island. Data depicted in Fig. 3C do not reveal any
consistent difference in the secretion of BAFF among the
strains.
H. pylori increase the cAMP level and activate PKA and CREB
signaling in MDMs
The signaling pathways that lead to BAFF expression involve
either the cAMP/PKA/CREB or the Jak/Stat axis, depending
on the stimuli (30, 31). Seeking for the pathway triggered by
H. pylori, we measured the intracellular cAMP levels in mac-
rophages incubated with bacteria. The infection of the cells led
to an increase of the cAMP level (Fig. 4A). cAMP regulates
many physiological processes via the activation of PKA that
phosphorylates CREB on serine 133. We examined the PKA
activity in macrophages infected with H. pylori, and we revealed
the phosphorylation of numerous proteins at a consensus PKA
phosphorylation site, reduced when cells were pretreated with
the PKA inhibitor H89 (Fig. 4B). In accordance with these data,
the infection with bacteria induced the phosphorylation of
CREB, and this event was prevented by H89 (Fig. 4B). To fi-
nally demonstrate that the cAMP/PKA/CREB axis activated by
H. pylori was determinant in the BAFF production, we quantified
the cytokine release by infected MDMs in presence or absence of
H89 and of the Jak inhibitor AG490. Results shown in Fig. 4C
indicate that the H. pylori–induced release of BAFF relies on
the cAMP-triggered pathway without any involvement of the
Jak/Stat pathway.
BAFF promotes the release of pro-Th17 cytokines by
monocytes
Although BAFF receptors are mainly expressed by B cells (32), it
is emerging that the role of the cytokine is not strictly limited to
the B cell biology. For example, the expression of one of the recep-
tors, BAFF-R, is upregulated by T cells after activation (33).
Moreover, the administration of BAFF to human monocytes en-
hances their survival, promotes their activation, in terms of release
of proinflammatory cytokines, and leads to their differentiation
into macrophage-like cells with a progressive expression of the
other BAFF receptor transmembrane activator and CAML inter-
actor (TACI) (34). Because chronic H. pylori–associated gastritis
is mainly accompanied by monocyte infiltration, in addition to
lymphocyte infiltration, we were interested to know whether the
exposure of monocytes to BAFF could lead to the release of pro-
Th17 cytokines. The release of IL-1b and IL-6 by monocytes,
after BAFF administration, was already shown (34), but the pos-
sibility that BAFF promotes also the secretion of the other two
cytokines, which are crucial in generating Th17 cells, namely, IL-
23 and TGF-b, has never been considered. Freshly isolated human
monocytes were exposed to BAFF, and the supernatant was har-
vested at different time intervals for determining the concentration
of the single cytokines by ELISA. We found that BAFF triggered
the secretion and the time-dependent accumulation of IL-1b and
IL-6 in the culture supernatant of monocytes (Fig. 5), even at
a concentration of BAFF lower than that applied in the previous
study. In addition, we found that BAFF triggered the secretion
of IL-23 and TGF-b (Fig. 5). We also verified that BAFF induced
the expression of all the cytokines at the mRNA level (data not
shown).
We did not exclude the possibility that BAFF, secreted by
macrophages, could act in an autocrine way on the same cells.
However, data obtained by exposing MDMs to BAFF suggested
that in vivo the contribution of macrophages in creating a pro-
Th17–enriched milieu is minimal. Moreover, the significant re-
duction of cytokine secretion by monocytes, in the presence of
the BAFF neutralizing Ab, enables the exclusion of any putative
contamination of the commercial cytokine by LPS (Fig. 5).
Interestingly, we found that H. pylori was able per se to promote
the release of pro-Th17 cytokines by monocytes, whereas the
effect on MDMs was scanty; to some degree, BAFF contributes to
this effect, as documented by the partial inhibition observed in
presence of the blocking Ab (Fig. 6). It is notable that the amount
of IL-1b released by monocytes exposed to BAFF is higher than
that released upon the infection of the same cells with H. pylori
(compare Fig. 5 with Fig. 6); considering the importance of IL-1b
FIGURE 4. cAMP production and PKA/CREB activation in MDMs exposed to H. pylori. (A) MDMs were infected 2 h with H. pylori, exposed 30 min to
20 mM forskolin, or left unstimulated before proceeding with the quantification of cAMP. (B) Immunoblot analysis of the phosphorylation state of PKA
substrates and of CREB in postnuclear supernatants of MDMs cultured 2 h with H. pylori. Where indicated, macrophages were pretreated for 1 h with
10 mM H89. Filter was stripped and reprobed with anti-actin Ab. (C) MDMs were treated for 1 h with 10 mM H89 or 25 mM AG490 before being infected
with H. pylori. After 72 h, supernatants were collected for BAFF content determination. Values are expressed as means6 SD of duplicate determinations of
three separate experiments. *p , 0.05, **p , 0.01.
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in the human Th17 polarization (35), it is plausible that the role of
BAFF in creating a pro-Th17 cytokine milieu especially pertains
to IL-1b.
Notably, once monocytes were incubated with the conditioned
medium of MDMs infected with H. pylori, they release pro-Th17
cytokines, whereas in the presence of the anti-BAFF Ab, the se-
cretion dropped (Supplemental Fig. 2). Collectively, these results
add support to the conclusion that H. pylori and the cytokine
BAFF, released by H. pylori–infected macrophages, cooperate in
activating monocytes to generate the cytokine mixture required for
the differentiation of Th17 cells.
BAFF induces monocytes to produce ROS, which are essential
for the production of pro-Th17 cytokines
ROS is a collective term to describe the chemical species formed by
incomplete reduction of oxygen, such as superoxide anion, hy-
drogen peroxide, and the hydroxyl radical. ROS are involved in
many signaling pathways leading to many different functions in-
cluding inflammation and immune response. Accordingly, ex-
pression of several genes encoding for cytokines are under the
control of transcription factors activated by ROS. We started by
verifying whether BAFF triggered ROS formation in monocytes.
To this aim, we took advantage of the well-known tracer H2DCF-
DA (36). Cells loaded with the tracer were exposed to BAFF, and
the fluorescence of the intracellularly cleaved and oxidized form
of the tracer, DCF, was monitored. Considering the fluorescence
of DCF proportional to the amount of ROS inside the cells, we
found that the administration of BAFF led to ROS accumulation in
monocytes (Fig. 7A, 7C). The kinetic of ROS production revealed
that this peaked after 2- to 3-h incubation with BAFF and, notably,
it was consistent with the kinetics of the pro-Th17 cytokine gene
expression (data not shown). If BAFF was preincubated with the
blocking Ab before being administrated to monocytes, the effect
was significantly reduced. Similarly, the treatment of monocytes
with DPI, a competitive inhibitor of flavin-containing cofactors that
prevents ROS production by NAD(P)H oxidase, NO synthase, and
mitochondrial complex I (37–39), strongly impaired BAFF-
induced ROS accumulation (Fig. 7A, 7C). Exposure of MDMs
to BAFF resulted in a small production of ROS, supporting once
more the idea that BAFF does not act in an autocrine way on the
same cells that produce the cytokine (Fig. 7B, 7D).
ROS production was observed also when monocytes, but not
MDMs, were infected with H. pylori (Supplemental Fig. 3).
However, in this case, although the effect on monocytes was ab-
rogated by DPI, it remained unaffected by the anti-BAFF Ab.
These results suggest that H. pylori leads to ROS production in
monocytes per se, independently of BAFF.
Interestingly, when monocytes and MDMs, independently of the
stimulus, were preincubated with DPI, the secretion of pro-Th17
cytokines was almost completely abrogated (Fig. 8 and data not
shown), in accordance with the impact that ROS have on cytokine
expression (40). The activation of the ROS-independent nonclas-
sical pathway of NF-kB, by BAFF, may account for the residual
cytokine secretion measured in the presence of DPI.
BAFF promotes the differentiation of Th17 cells by acting
directly on proliferating CD4+ cells
To assess the impact of BAFF on human Th cell polarization, we
exposed enriched human CD4+ T cells from healthy donors to
BAFF and primed them by TCR/CD3/CD28 cross-linking using
immobilized anti-CD3 and anti-CD28 mAbs. After 10 d, cells
were washed and restimulated for 48 h using anti-CD3 mAb in
ELISPOT microplates coated with anti–IL-17 Ab. The number of
IL-17–forming cells was determined by ELISPOT analysis of
FIGURE 5. Administration of BAFF to monocytes promotes the se-
cretion of pro-Th17 cytokines. Monocytes and MDMs were exposed to
rBAFF (50 ng/ml) in the presence or absence of BAFF blocking Ab (1 mg/
ml). At the indicated time points, culture supernatants were collected for
cytokine content determination. Values are expressed as means 6 SD of
duplicate determinations of four separate experiments. *p , 0.05, **p ,
0.01, ***p , 0.001.
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cytokine production. As shown in Fig. 9, priming of cells that had
been exposed to BAFF resulted in a remarkable production of the
Th17 cytokine, IL-17, suggesting that BAFF is able to promote
a polarized Th17 response. No significant enhancement in IL-17
greater than the levels produced by T cells primed in neutral
conditions (TCR/CD3/CD28 cross-linking alone) was observed
when cells were pretreated with the anti-BAFF Ab, thus high-
lighting the Th17 driving activity of BAFF.
Discussion
It is well established that the human infection by H. pylori results
in an interplay between the bacterium and the host. H. pylori
releases several virulence factors that per se harm the gastric
mucosa; moreover, in virtue of its capacity to modulate the im-
mune response, it exacerbates the disease because of the strong
inflammation evoked. Finally, despite the robust adaptive immune
response, H. pylori survives in the host for a long time.
The question addressed by this study was how H. pylori leads to
the development of the Th17 immune response. Different studies
have demonstrated that the activation of BAFF and APRIL signal
transduction pathways may contribute to both H. pylori–inde-
pendent and H. pylori–dependent growth of gastric MALT lym-
phomas (41, 42). Our investigation stemmed from the evidence,
obtained in two different models of autoimmune disease, that
BAFF is a cytokine crucial in promoting the expansion of Th17
cells (11, 12). None of these two studies, however, defined how
BAFF leads to the generation of Th17 cells: whereas one study
suggested a direct action of BAFF on T cells (11), the other
concluded that probably BAFF is an important modulator of the
cytokine milieu that affects the differentiation of the specific T cell
subset (12). With the aim to investigate the involvement of BAFF
in the H. pylori–induced disease, we started analyzing the ex-
pression of the cytokine in infected patients with chronic gastritis.
We found that BAFF strongly accumulated in the gastric mucosa
of patients and, notably, its expression decreased after H. pylori
ET; the evidence that, in chronic gastritis not attributable to
H. pylori infection, the cytokine was poorly represented further
supported the conclusion that the bacterium exerts a crucial role in
inducing BAFF. It is notable that, in the same specimens, IL-17
showed an expression superimposable to that of BAFF, thus
leading to the first conclusion of our study that an axis BAFF/
Th17 exists in H. pylori–infected patients. When we looked for the
source of BAFF in the gastric mucosa, we found that this cytokine
abundantly accumulated in monocytes/macrophages and, in ac-
cordance with this observation, the infection of MDMs with living
H. pylori, in vitro, led to the secretion of BAFF. Moreover, we
found that the main H. pylori inducer of BAFF is a TLR4 ligand:
this could be LPS and/or another PAMP, such as the protein
HP0175 that promotes the secretion of IL-23 via TLR4 signaling
(43). We excluded any contribution by the vacuolating cytotoxin
VacA, by the immune modulatory protein HP-NAP, and by the
Cag pathogenicity island. We also demonstrated that H. pylori–
induced BAFF secretion relies on the cAMP/PKA/CREB pathway.
The second important finding of this investigation was the role of
BAFF in creating a pro-Th17 cytokine milieu. The possibility that
BAFF could exert its effects not only on B and T cells, but also on
innate immune cells and, in particular, on monocytes, was previ-
ously considered, and it was shown that monocytes activated by
BAFF secreted a significant amount of IL-6 and IL-1b, two of the
cytokines crucial for leading the differentiation of Th17 cells (34).
In accordance with this evidence, we found that the administration
of a recombinant form of BAFF to monocytes, cells well repre-
sented in H. pylori–associated gastritis, resulted in the generation
of the cytokine milieu required for the differentiation of Th17
FIGURE 6. Infection of monocytes and MDMs with H. pylori promotes
the secretion of pro-Th17 cytokines. Monocytes and MDMs were exposed
to H. pylori (MOI = 0.5) in the presence or absence of 1 mg/ml BAFF
blocking Ab. At the indicated time points, culture supernatants were
collected for cytokine content determination. Values are expressed as
means 6 SD of duplicate determinations of two separate experiments.
*p , 0.05.
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cells, enriched not only in IL-6 and IL-1b, but also in TGF-b and
IL-23. Similarly, the exposure of monocytes to a conditioned
medium of MDMs infected with H. pylori also resulted in the
accumulation of pro-Th17 cytokines, and this effect was signifi-
cantly impaired when a neutralizing anti-BAFF Ab was present.
This finding, obtained with an experimental setup, which mimics
the in vivo infection, corroborates the conclusion that macrophage-
secreted BAFF may lead to the development of the Th17 profile in
the gastric mucosa of H. pylori–infected patients. Interestingly,
although we found that H. pylori is capable per se to activate
the secretion of pro-Th17 cytokines by monocytes in a BAFF-
independent manner, thus suggesting a cooperation of the two
mechanisms, the exposure of monocytes to BAFF resulted in
a greater release of IL-1b compared with cells infected with
bacteria. IL-1b is crucial in the human Th17 polarization (35);
therefore, it is plausible that the role of BAFF in creating a pro-
Th17 cytokine milieu especially pertains to IL-1b.
Notably, both H. pylori and BAFF had minimal effect on
MDMs in terms of producing release of pro-Th17 cytokines, if
compared with monocytes. This reduced reactivity of MDMs is
not a new finding and reflects the evidence that macrophages are
less sensitive to proinflammatory stimuli than monocytes, at least
for what concerns lung macrophages (44, 45).
Accumulating evidence suggests that radical oxygen species
(ROS), generated by inflammatory cells, not only help to kill
pathogens but also act on the inflammatory cells themselves, al-
tering the intracellular redox balance and functioning as signaling
molecules involved in the regulation of inflammatory and immu-
nomodulatory genes. Indeed, at the transcriptional level, ROS play
a key role in the control of NF-kB, AP-1, and other transcription
factors involved in gene expression of both inflammatory and
immune mediators. In agreement with this notion, we found that
BAFF and H. pylori trigger ROS production in monocytes, but not
in MDMs, and the radicals are essential for the production of the
pro-Th17 cytokines: indeed, the secretion of all the cytokines
declined after the administration of DPI. Ranging the inhibitory
effect of DPI from NADPH to mitochondrial complex I, we
cannot precisely define the source of ROS induced by BAFF, but
this is beyond the scope of this study and deserves further in-
vestigation.
The final question addressed in this study was the ability of
BAFF in directly promoting the differentiation of Th17 cells, as
suggested elsewhere (11). In this study, we have demonstrated
that, besides indirect effect, involving innate immune cells and the
generation of a peculiar cytokine milieu, BAFF is able to promote
directly the development of Th17. This finding supports the con-
FIGURE 7. BAFF triggers ROS production in mono-
cytes. (A and B) Monocytes and MDMs were ex-
posed to 50 ng/ml rBAFF, in the presence or absence of
1 mg/ml BAFF blocking Ab, for different time inter-
vals. Cells were loaded with the probe H2DCF-DA and
fluorescence was measured. (C and D) The same ex-
periment as in (A) and (B) was performed pretreating
the cells with 20 mM DPI. Data are expressed as
n-folds relative to negative control (cells exposed to
PBS). Values are expressed as means 6 SD of dupli-
cate determinations of four separate experiments.
**p , 0.01, ***p , 0.001.
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clusion reached by Zhou and colleagues with the study carried out
in a mouse model of autoimmune encephalomyelitis (11).
In summary, our observations document the existence of a
BAFF/Th17 axis in H. pylori–associated chronic gastritis, and they
pointed out the role of the bacterium in creating this specific im-
mune scenario. In contrast, the fact that the receptors for BAFF are
expressed on other T cell subsets and the evidence that this cy-
tokine contributes to their differentiation (46) enable us to spec-
ulate that in the gastric milieu of H. pylori–infected patients,
BAFF might also cooperate in the differentiation of Th1 and
regulatory T cells, the two lymphocyte subsets that together with
Th17 are well represented in the stomach of the patients (47–49).
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Supplementary Table I. Gastritis grading distribution among the considered series*. 
 
 
*Only samples from gastric antrum were selected and used in the study. Grading is defined as the 
measure of the severity of the mononuclear inflammatory lesions. Normal gastric mucosa contains 
only individual scattered chronic inflammatory cells in the lamina propria. Thus, any increase 
indicates chronic gastritis. The semi-quantitative assessment of the severity of mononuclear 
inflammation was graded in a three-tier scale: 
Score 0= no increase in comparison to normal gastric mucosa 
Score 1= slight increase of mononuclear cells in the lamina propria 
Score 2= moderate increase without evident follicles or lymphoid nodules 
Score 3= marked increase and/or follicles or lymphoid nodules within the lamina propria. 
# Normal gastric mucosa 
from dyspeptic patients 
Hp+ gastritis Post Hp-eradication  Hp- gastritis 
1 0 2 1 1 
2 0 2 0 1 
3 0 2 1 1 
4 0 1 1 1 
5 0 2 1 1 
6 0 2 0 1 
7 0 2 1 1 
8 0 1 0 1 
9 0 2 0 1 
10 0 2 0 1 
 
 
 
Supplementary Figure 1. Expression of pro-Th17 cytokines in dyspeptic patients with normal 
mucosa, Hp+ patients with chronic gastritis pre and post eradication (post ET) and Hp- patients 
with chronic gastritis. mRNA was extracted from gastric biopsies and retro-transcribed. Expression 
of IL-1β, IL-6, TGF-β, IL-23p19 and IL-12p40 genes was evaluated as detailed in Materials and 
Methods section. (n = 10 for each group of patients). Error bars = S.D. *, p < 0.05, **, p <0.01, ***, 
p < 0.001. 
  
Supplementary Figure 2. BAFF secreted by Hp-infected MDMs promotes the release of pro-Th17 
cytokines by monocytes. MDMs were infected by Hp (MOI = 0.5) for 72 h; collected supernatants 
were applied to freshly isolated monocytes in presence or absence of the anti-BAFF blocking 
antibody. After 96 h the amount of the pro-Th17 cytokines secreted was quantified by ELISA. 
Values are expressed as means ± SD of duplicate determinations of three separate experiments. *, p 
< 0.05, **, p <0.01. 
 
 
Supplementary Figure 3: Hp triggers ROS production in monocytes. (A, B) Monocytes and 
MDMs were exposed to Hp (MOI = 0.5), in presence or absence of 1 μg/ml BAFF blocking 
antibody for different time intervals. Cells were loaded with the probe H2DCF-DA and fluorescence 
was measured. (C, D) The same experiment as in A and B was performed pre-treating the cells with 
20 μM DPI. Data are expressed as n-folds relative to negative control (cells exposed to PBS). 
Values are expressed as means ± SD of duplicate determinations of four separate experiments. **, p 
< 0.01, *** p<0. 001.  
